SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Healthcare >

TransEnterix Inc. (TRXC)

TRXC RSS Feed
Add TRXC Price Alert      Hide Sticky   Hide Intro
Moderator: beambe, XJINVESTOR, SPORT19, n3m3sis
Search This Board: 
Last Post: 11/21/2017 4:08:54 PM - Followers: 147 - Board type: Free - Posts Today: 31

http://www.transenterix.com/


TransEnterix, Inc. operates as a development stage medical device company. The company is focused on the development and commercialization of SurgiBot™, a novel patient side minimally invasive surgical robotic system. It uses flexible instruments and robotics to improve the outcomes of minimally invasive surgery. The company was formerly known as SafeStitch Medical, Inc. after merger it has changed its name to TransEnterix, Inc. TransEnterix was founded in August 1988 and is headquartered in Morrisville, NC.

TRXC has finalized its design for the SurgiBot and will submit the device for FDA(510)k clearance in Q4 of 2014, expecting approval and commercialization in mid 2015.

The SurgiBot will retail for $500,000, and will be the first surgical robot on the market to compete with Intuitive Surgical's Da Vinci System for a fraction of the price. 

The SurgiBot has 100% tactile feedback, a huge feature that all surgeons look for when conducting surgery. TransEnterix's competitors, like TITXF, who is still far behind in the development of their SPORT system when compared to TransEnterix, has zero tactile and zero haptic feedback.

TRXC has 6 professional analysts covering the stock, all with buy ratings, and price targets as low as $6.00 per share, and as high as $10.00 per share. 

Oct 13 (Reuters) - U.S. FDA -

* FDA clears Senhance System, Transenterix Inc's new robotically-assisted surgical device for adult patients ‍? Source: (http://bit.ly/2wUfB9N) Further company coverage:

Events:
 

European Society of Gynaecological Oncology
Vienna, Austria
4 Nov - 7 Nov

TransEnterix Schedules Third Quarter 2017 Financial and Operating Results Conference Call for November 9, 2017

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release third quarter 2017 financial and operating results after the market closes on Thursday, November 9, 2017. Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these results starting at 4:30 pm Eastern Time the same day. The call will be concurrently webcast.

To listen to the conference call on your telephone, please dial (844) 804-5261 for domestic callers and (612) 979-9885 for international callers, and reference conference ID 8898746 approximately ten minutes prior to the start time. To access the live audio webcast or archived recording, use the following link http://ir.transenterix.com/events.cfm. The replay will be available on the Company's website.

 

AAGL Global Congress 2017
National Harbor, MD
12 Nov - 16 Nov
National Harbor, Maryland USA

TransEnterix to Present at the Stifel 2017 Healthcare Conference

TransEnterix, Inc. (NYSE MKT:TRXC) announced today (31/10/2017) that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Stifel 2017 Healthcare Conference at The Lotte New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 5:00 PM Eastern Time on Tuesday, November 14, 2017.


 
SureTrader
Interactive Brokers Advertisement
TRXC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
News News Alert: Amended Statement of Beneficial Ownership (sc 13d/a) 11/21/2017 06:03:02 AM
PostSubject
#4044  Sticky Note A really important article about Senhance!!! H2004 11/20/17 11:32:28 AM
#4039  Sticky Note IMPORTANT ARTICLE ABOUT SENHANCE SPORT19 11/20/17 11:18:14 AM
#3528  Sticky Note Great information on this blog. Make sure you XJINVESTOR 11/04/17 05:30:56 PM
#4113   Of course he did not want $12.50...have you not_again 11/21/17 04:08:54 PM
#4112   Pump,pump,pump Railrazor63 11/21/17 04:06:21 PM
#4111   You only show when insiders are dumping shares, WHY? not_again 11/21/17 04:05:17 PM
#4110   Johnny, You may just get you 7 before Belus 11/21/17 04:03:55 PM
#4109   You bring pumping to a new level. Johnny_C 11/21/17 03:45:30 PM
#4108   We have found our base, :) Only going Belus 11/21/17 02:16:50 PM
#4107   That is very deceiving. Less than Johnny_C 11/21/17 02:01:38 PM
#4106   Do we need to report this Dr. for money01 11/21/17 01:49:23 PM
#4105   This is a game of chess. Sacrifice pawns Ai2020 11/21/17 12:36:50 PM
#4104   Excellent DD! Thanks for posting Answered a couple of my questions. SPORT19 11/21/17 12:13:32 PM
#4103   Where do you come up with this stuff? MJACK 11/21/17 12:05:45 PM
#4102   Duke Health System Just put an order for Dr_Biotechguru5 11/21/17 12:04:01 PM
#4100   CFO just dumped shares at less than 3 SPORT19 11/21/17 11:35:24 AM
#4099   I think they are Voting on something, Not Belus 11/21/17 11:30:22 AM
#4098   December 2017 $3.00 call options up 200% on Dr_Biotechguru5 11/21/17 11:24:30 AM
#4097   TRXC: Stryker Corp. just outbid ISRG $12.50 per Dr_Biotechguru5 11/21/17 11:22:43 AM
#4096   No Volume for a Pump and Dump, this Belus 11/21/17 10:33:50 AM
#4095   Is this setting up to be another pump Longmoney 11/21/17 10:25:22 AM
#4094   Very Nice, Belus 11/21/17 10:23:50 AM
#4093   What is this transaction with Aisling Capital? They GodHelpUs 11/21/17 10:09:12 AM
#4092   Creamer mentioned TRXC on last night show. MJACK 11/21/17 09:54:15 AM
#4091   Lower Volume today, Is a great sign, Moving Belus 11/21/17 09:44:13 AM
#4090   you've lost your mind man!!! myke2 11/21/17 09:28:30 AM
#4089   Really????? What did he say about TRXC????? myke2 11/21/17 09:25:29 AM
#4088   TRXC mentioned on Mad Money. Blessing or Curse? MJACK 11/21/17 08:49:48 AM
#4087   Very Good,2 pots of pressed Italian Roast for me. Belus 11/21/17 08:42:12 AM
#4086   My daily dose of Biotech espresso! Skaarg War Lord 11/21/17 08:24:41 AM
#4083   If you look back at Volume we have Belus 11/21/17 12:08:10 AM
#4082   They don't have a problem SELLING SHARES! not_again 11/20/17 10:47:04 PM
#4080   I would absolutely be interested. Thank you, H2004 Longmoney 11/20/17 10:09:18 PM
#4079   @Longmoney...It might not be so strange and difficult H2004 11/20/17 08:55:10 PM
#4078   So strange why TRXC has such a hard Longmoney 11/20/17 07:04:54 PM
#4077   Did you know that the Senhance Surgical Robotic H2004 11/20/17 06:20:23 PM
#4075   Again, great PR for "TransEnterix Senhance laparoscopic platform" H2004 11/20/17 05:49:05 PM
#4073   Ramping up? sleuth100 11/20/17 03:35:27 PM
#4068   No No.. It is Alphabet ..... they nowlurking 11/20/17 02:22:55 PM
#4067   Stifel Advisors San Jose office advised both ISRG Dr_Biotechguru5 11/20/17 02:14:04 PM
#4066   TRXC has multiple offers from US and Japanese Dr_Biotechguru5 11/20/17 01:51:08 PM
#4065   i am LONG and know we have a jcscottsdale 11/20/17 01:21:04 PM
#4063   lolol not_again 11/20/17 12:49:38 PM
#4062   CVRS next juancarlos 11/20/17 12:46:29 PM
#4061   "Trading Halt"...CODE FOR..insiders getting ready to dump again.. not_again 11/20/17 12:43:52 PM
#4060   You posted something similar on 10/27/17... H2004 11/20/17 12:32:49 PM
#4059   Sorry, your "Fly On The Wall" got squashed. H2004 11/20/17 12:29:31 PM
#4058   ISRG: Tender offer $12.50 per share. Dr_Biotechguru5 11/20/17 12:27:44 PM
#4057   Lmao!! Adrock 11/20/17 12:26:06 PM
#4056   Fly On The Wall: TRXC Sr. Management team Dr_Biotechguru5 11/20/17 12:22:47 PM
#4055   Too bad the CFO didn't know about the SPORT19 11/20/17 12:19:25 PM
#4054   I get it. Just meaning they have set SPORT19 11/20/17 12:09:16 PM
#4053   Oh hell yeah!!!! Trading halt any minute per Longmoney 11/20/17 12:06:32 PM
PostSubject